financetom
Business
financetom
/
Business
/
China to safeguard equal treatment for foreign-funded firms
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
China to safeguard equal treatment for foreign-funded firms
Mar 24, 2024 7:55 PM

BEIJING (Reuters) -China will safeguard equal treatment for foreign-funded firms, so that more foreign-funded enterprises can invest in the country with confidence and peace of mind, said Commerce Vice Minister Guo Tingting on Monday.

China will further expand high-level opening up to the outside world and create more market opportunities, said Guo at the China Development Forum in Beijing.

Guo did not give specific details about so-called national treatment - giving foreign individuals the same treatment as one's own nationals, as per World Trade Organization (WTO) principles.

"China will fully guarantee national treatment for foreign companies, so that more foreign companies can invest in China with confidence and peace of mind," Guo said.

China will firmly safeguard multilateral trading system with the WTO at its core, she said.

Over 100 overseas executives and investors were attending the forum and a series of smaller closed-door sessions with Chinese officials on March 24-25.

Foreign direct investment into China contracted by 8% last year, reflecting a shaky economic recovery and tension with the United States and its allies on a range of issues.

Chinese officials have been stepping up efforts to attract investors at a time when many companies have been looking to "de-risk" supply chains and operations away from China.

Premier Li Qiang said on Sunday that China will continue its efforts to build a first-class business environment and welcome enterprises from all over the world to invest in the country.

Earlier this month, China announced an economic growth goal of around 5% for this year and promised to transform the country's development model to offset drag from a prolonged property crisis, high local government debt and weak consumer demand.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved